Description: HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
news (24502) health (20234) research (8528) medical (6550) science (6051) healthcare (5794) medicine (3125) drugs (1027) treatments (659) fda (359)
News Media Medical World News Podcasts Shows State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Podcasts Medcast Videos Peer Exchange Peers & Perspectives Conferences Conference Coverage Conference Listing Partners CME/CE Resources Interactive Tools Live Events Press Release Publications Sponsored Subscribe Spotlight Biosimilars Spotlight COVID-19 FDA News Qazi Corner This Year In Medicine 2022 Clinical ADHD Allergy Arterial Disease Cardiology Dermatology
May 9th 2023
Announced just more than a year after AstraZeneca announced topline results, the FDA has approved a label expansion to include reducing cardiovascular death and HF hospitalizations for dapagliflozin based on results of the phase 3 DELIVER trial.